Important news for small and medium-sized enterprises (SMEs) in the biomedical sector! A new government subsidy has been launched, providing €30 million to support innovation in regenerative medicine. We are pleased to inform you, especially after the considerable effort we've exerted to make it a reality.

The Dutch government is investing €30 million to support collaboration between SMEs and researchers through a subsidy scheme called ‘Subsidieregeling Regeneratief Geneeskundige Onderzoeksprojecten’ (SRGO). In brief, this subsidy scheme provides a loan to the company and a grant to the academic partner.

Minister Micky Adriaansens published the subsidy scheme on May 15, 2024, emphasizing the importance of collaboration between science and SMEs.

“The Netherlands excels in developing new technologies, such as regenerative medicine, where the body's self-healing ability is stimulated. The SRGO subsidy scheme helps to enhance collaboration between science and SMEs. This allows us to translate even more knowledge into innovations.”

The subsidy scheme will be funded by the Ministry of Economic Affairs and Climate Policy and the Ministry of Health, Welfare, and Sport and will be executed by the Netherlands Enterprise Agency (RVO)

The total budget of the SRGO is available in parts through 3 tenders. The first one opens for applications from July 1st until December 2nd, 2024. Make sure to take advantage of this valuable opportunity to secure funding for your innovative projects!

More information

During the RegMed XB Annual Conference on June 12-13 in Maastricht, the RVO will provide additional details on the subsidy scheme as part of the RegMed XB Annual Conference.

For detailed information about the subsidy, please refer to this PDF document (Dutch) or visit RVO.

We are glad this opportunity is open and strongly encourage its utilization. If assistance is needed in finding a suitable match, please feel free to reach out to our business developers.